MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Epidemiological, clinical and paraclinical characteristics of paroxysmal dystonia in multiple sclerosis : A study of Tunisian cohort

    M. Adouania, H. Derbali, I. Bedoui, M. Messelmani, M. Ben Mahmoud, N. Ghedamsi, M. Mansour, J. Zaouali, R. Mrissa (Tunis, Tunisia)

    Objective: To describe the specificities of paroxysmal dystonia (PD) in a cohort of Tunisian Multiple Sclerosis (MS). Background: Movements disorders are uncommon in multiple sclerosis.…
  • 2023 International Congress

    Health status of Lewy Body Dementia caregivers predicts psychological response to peer mentoring intervention

    M. Suresh, K. Woo, J. Fleisher (Chicago, USA)

    Objective: To understand how caregiver health status influences response to a peer mentoring intervention in caregivers of individuals with Lewy Body Dementia (LBD). Background: Caregiving…
  • 2023 International Congress

    Globus pallidus interna deep brain stimulation for Parkinson’s Disease: Impact on Restless Legs Syndrome

    A. Wiltshire, A. Mahes, S. Wang, R. Zuzuárregui (San Francisco, USA)

    Objective: The goal of this study was to evaluate the impact of deep brain stimulation (DBS) of the globus pallidus interna (GPi) on Restless Legs…
  • 2023 International Congress

    Jerky dystonic hand revisited: post-stroke thalamic tremor

    S. Garg, K. Shetty, C. H M, N. Sharma (Bangalore, India)

    Objective: To assess phenomenology and clinical- radiological correlation of post thalamic stroke movement disorders (MDs) Background: Post stroke movement disorders (PSMD) are rare and have…
  • 2023 International Congress

    Post stroke Restless Limb Syndrome and its impact on sleep and life quality in patients in Rural Gujarat, India

    S. Desai, J. Darji, D. Desai (Anand, India)

    Objective: We aimed to assess the prevalence of RLS in patients with brain stroke and assess its impact on sleep and quality of life. We…
  • 2023 International Congress

    Subjective cognitive complaints in patients with progressive supranuclear palsy and corticobasal syndrome

    JS. Lee, JH. Ahn, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: In the present study, we evaluate a prevalence of subjective cognitive complaints (SCC)in patients with progressive supranuclear palsy (PSP) as well as clinical features…
  • 2023 International Congress

    Building a consensus conceptual model of meaningful symptoms and impacts in early Parkinson’s disease

    J. Adams, J. Mammen, C. Kopil, Y. Xiao, D. Stephenson, T. Simuni (Rochester, USA)

    Objective: To develop a consensus based conceptual model of meaningful symptoms and impacts in early Parkinson’s disease (PD) through aligning of PD qualitative research carried…
  • 2023 International Congress

    Alzheimer’s Disease Co-pathology and its Influence on Biofluid Biomarkers in Autopsied Subjects from the PPMI Study

    D. Coughlin, K. Hwang, E. Bayram, D. Galasko (San Diego, USA)

    Objective: To examine the relationship between biofluid biomarkers and post-mortem pathological findings in autopsied subjects from the Parkinson’s Progression Marker Initiative (PPMI). Background: The PPMI…
  • 2023 International Congress

    Operationalising goal setting as an outcome measure: Experience from the PRIME-UK randomised controlled trial

    E. Tenison, K. Lloyd, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To select a suitable primary outcome for the evaluation of a multicomponent intervention for people with parkinsonism. Background: The multicomponent PRIME model of care,…
  • 2023 International Congress

    Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism

    R. Matmurodov, E. Abduqodirov, R. Juraev, O. Naimov, B. Muminov, K. Khalimova, H. Daminova (Tashkent, Uzbekistan)

    Objective: To analysis of glial neurotrophic factor content in blood serum of patients with PD and VP. Background: Parkinson's disease (PD)  and vascular parkinsonism (VP)…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley